Paysign, Inc. PAYS revenue by segment, product and geography
In its fiscal year ending 2025-12-31, Paysign, Inc. reported revenue across 5 products and services; the largest, Plasma Industry, was $45.6M, 55.3% of the filed sum (+4.0% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Plasma Industry$45.6M55.3%+4.0% yoy
- Pharma Industry$33.9M41.1%+167.8% yoy
- Other Revenue$2.52M3.1%+36.2% yoy
- Breakage Revenue$475K0.6%+95.9% yoy
- Settlement Revenue$00.0%-100.0% yoy
Members sum to the consolidated $82M for this period.
- Pharma Industry$15.7M55.7%+81.9% yoy
- Plasma Industry$11.7M41.7%+24.9% yoy
- Other Revenue$610K2.2%+7.2% yoy
- Breakage Revenue$112K0.4%+10.7% yoy
- Settlement Revenue$00.0%no prior
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.